Compassionate use experience with dasatinib therapy in patients after imatinib and/or nilotinib failure

被引：0
|
作者：
Gunawardena, Bettina A. [1 ]
Schlief, Sarah [1 ]
Dempke, Wolfram [1 ]
Wnterhalter, Bernd [1 ]
机构：
[1] Bristol Myers Squibb GmbH & Co KGaA, Munich, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4561.4561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4561
引用
收藏
页码：212B / 212B
页数：1
相关论文
共 50 条
  • [21] MDR-1 expression predicts molecular response in CML patients on nilotinib therapy after imatinib failure
    Agrawal, M.
    Erben, Philipp
    Mueller, Martin Christian
    Daikeler, Hannah
    Schenk, Thomas
    Hanfstein, Benjamin
    Hochhaus, Andreas
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 41 - 41
  • [22] Infectious Events In Patients with Chronic Myeloid Leukemia Treated with Nilotinib as a Front Line Therapy and After Imatinib Failure
    Al-Ameri, Ali M.
    Cortes, Jorge E.
    Kantarjian, Hagop
    Burton, Elizabeth
    Quintas-Cardama, Alfonso
    Jabbour, Elias
    Badoux, Xavier
    O'Brien, Susan
    Mattiuzzi, Gloria
    BLOOD, 2010, 116 (21) : 527 - 527
  • [23] Treatment with nilotinib for patients with chronic myeloid leukemia (CML) who failed prior therapy with imatinib and dasatinib.
    Jabbour, Elias
    Kantarjian, Hagop
    Giles, Francis
    O'Brien, Susan
    Cortes, Jorge
    BLOOD, 2006, 108 (11) : 616A - 616A
  • [24] Cross-intolerance to imatinib, dasatinib and nilotinib therapy in a patient with chronic myeloid leukaemia
    Novitzky-Basso, Igor
    Craddock, Charles
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (06) : 548 - 549
  • [25] Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN 107) therapy failure
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Jones, Dan
    Nicaise, Claude
    O'Brien, Susan
    Giles, Francis
    Talpaz, Moshe
    Cortes, Jorge
    BLOOD, 2007, 109 (02) : 497 - 499
  • [26] EFFICACY AND SAFETY OF DASATINIB IN CML/ALL PH1+ IMATINIB RESISTANT PATIENTS IN A COMPASSIONATE USE PROGRAM
    Gozzini, A.
    Bosi, A.
    Santini, V
    Stagno, F.
    Di Raimondo, F.
    Abruzzese, E.
    Breccia, M.
    Alimena, G.
    Gobbi, M.
    Martinelli, G.
    Sora, F.
    Sica, S.
    Luciano, L.
    Rotoli, B.
    Cambrin, Rege G.
    Saglio, G.
    Orlandi, E.
    Lazzarino, M.
    HAEMATOLOGICA, 2008, 93 : S37 - S37
  • [27] A Retrospective Analysis of Treatment Patterns in Elderly Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As Second-Line Therapy after Imatinib
    Smith, B. Douglas
    Liu, Jun
    Latremouille-Viau, Dominick
    Zhou, Zhou
    Guerin, Annie
    Fernandez, Daniel
    Yi, Dingdong
    Wang, Xufei
    Wu, Eric Q.
    Mhatre, Shivani K.
    Keir, Christopher H.
    Chen, Lei
    BLOOD, 2014, 124 (21)
  • [28] BCR-ABL kinase domain mutations and their kinetics on second line dasatinib or nilotinib therapy in CML patients after imatinib failure: A cooperative evaluation of four different detection methods
    Ernst, Thomas
    Gruber, Franz
    Pelz-Ackermann, Oliver
    Mueller, Martin C.
    Mikkola, Ingvild
    Porkka, Kimmo
    Niederwieser, Dietger
    Hochhaus, Andreas
    Lange, Thoralf
    BLOOD, 2007, 110 (11) : 101A - 101A
  • [29] Outcome of Patients with CML Treated with Dasatinib or Nilotinib after Failure of Second Prior TKIs.
    Rossi, Antonella Russo
    Breccia, Massimo
    Castagnetti, Fausto
    Luciano, Luigiana
    Gozzini, Antonella
    Annunziata, Mario
    Martino, Bruno
    Stagno, Fabio
    Cavazzini, Francesco
    Tiribelli, Mario
    Visani, Giuseppe
    Pregno, Patrizia
    Musto, Pellegrino
    Fava, Carmen
    Avanzini, Paolo
    Turri, Diamante
    Sgherza, Nicola
    Albano, Francesco
    Specchia, Giorgina
    BLOOD, 2010, 116 (21) : 946 - 946
  • [30] Nilotinib therapy after dasatinib failure in patients with imatinib-resistant or -intolerant chronic myeloid leukemia (CML) in chronic phase (CP), accelerated phase (AP) or blast crisis (BC)
    Giles, Francis J.
    le Coutre, Phillip
    Bhalla, Kapil N.
    Ossenkoppele, Gert
    Alimena, Giuliana
    Haque, Ariful
    Gallagher, Neil
    Kantarjian, Hagop M.
    BLOOD, 2007, 110 (11) : 311A - 312A
12345